AU2017273415B2 - Treatment for Parkinson's disease - Google Patents
Treatment for Parkinson's disease Download PDFInfo
- Publication number
- AU2017273415B2 AU2017273415B2 AU2017273415A AU2017273415A AU2017273415B2 AU 2017273415 B2 AU2017273415 B2 AU 2017273415B2 AU 2017273415 A AU2017273415 A AU 2017273415A AU 2017273415 A AU2017273415 A AU 2017273415A AU 2017273415 B2 AU2017273415 B2 AU 2017273415B2
- Authority
- AU
- Australia
- Prior art keywords
- formula
- compound
- hydrogen
- disease
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201621019087 | 2016-06-02 | ||
| IN201621019087 | 2016-06-02 | ||
| IN201621019185 | 2016-06-02 | ||
| IN201621019185 | 2016-06-02 | ||
| PCT/IN2017/050224 WO2017208267A1 (en) | 2016-06-02 | 2017-06-02 | Treatment for parkinson's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2017273415A1 AU2017273415A1 (en) | 2018-12-06 |
| AU2017273415B2 true AU2017273415B2 (en) | 2023-01-19 |
Family
ID=59388123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2017273415A Ceased AU2017273415B2 (en) | 2016-06-02 | 2017-06-02 | Treatment for Parkinson's disease |
Country Status (27)
| Country | Link |
|---|---|
| US (4) | US10849887B2 (enExample) |
| EP (2) | EP3463351B1 (enExample) |
| JP (1) | JP6974357B2 (enExample) |
| KR (1) | KR102508288B1 (enExample) |
| CN (1) | CN109475539B (enExample) |
| AU (1) | AU2017273415B2 (enExample) |
| CA (1) | CA3024976A1 (enExample) |
| CL (1) | CL2018003431A1 (enExample) |
| CY (1) | CY1125285T1 (enExample) |
| DK (1) | DK3463351T3 (enExample) |
| ES (1) | ES2914782T3 (enExample) |
| HR (1) | HRP20220683T1 (enExample) |
| HU (1) | HUE059387T2 (enExample) |
| IL (1) | IL263188B (enExample) |
| LT (1) | LT3463351T (enExample) |
| MX (1) | MX385276B (enExample) |
| MY (1) | MY193754A (enExample) |
| NZ (1) | NZ748592A (enExample) |
| PH (1) | PH12018502457B1 (enExample) |
| PL (1) | PL3463351T3 (enExample) |
| PT (1) | PT3463351T (enExample) |
| RS (1) | RS63243B1 (enExample) |
| SG (1) | SG11201810294QA (enExample) |
| SI (1) | SI3463351T1 (enExample) |
| SM (1) | SMT202200228T1 (enExample) |
| UA (1) | UA123018C2 (enExample) |
| WO (1) | WO2017208267A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2911040C (en) | 2012-05-02 | 2021-11-16 | Georgetown University | Treating an .alpha.-synucleinopathy with tyrosine kinase inhibitors |
| KR102508288B1 (ko) | 2016-06-02 | 2023-03-09 | 썬 파마 어드밴스트 리서치 컴패니 리미티드 | 파킨슨병의 치료 |
| CN110606840A (zh) | 2018-06-15 | 2019-12-24 | 日产化学株式会社 | 5-炔基吡啶化合物的制造方法 |
| EP3883935A4 (en) | 2018-11-20 | 2022-08-10 | Georgetown University | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE, MYODEGENERATIVE AND LYSOSOMAL STORAGE DISORDERS |
| KR20220024463A (ko) * | 2019-06-11 | 2022-03-03 | 썬 파마 어드밴스트 리서치 컴패니 리미티드 | 시뉴클레인병증에 대한 치료 |
| WO2021030783A1 (en) * | 2019-08-15 | 2021-02-18 | Duke University | Compositions and methods for the treatment cancer and cns disorders |
| AU2021317186A1 (en) | 2020-07-31 | 2023-03-16 | Sun Pharma Advanced Research Company Limited | N'-(2-chloro-6-methylbenzoyl)-4-methyl-3-[2-(3-quinolyl)ethynyl]-benzohydrazide for treatment of Alzheimer's Disease |
| US20250275953A1 (en) | 2022-05-02 | 2025-09-04 | Sun Pharma Advanced Research Company Ltd. | Vodobatinib for reducing progression of parkinson's disease |
| WO2025058473A1 (ko) | 2023-09-14 | 2025-03-20 | 주식회사 엑소스템텍 | 퇴행성 뇌질환 치료 단백질을 포함하는 엑소좀을 이용한 뇌 특이적 퇴행성 뇌질환 치료 단백질 전달 기술 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012098416A1 (en) * | 2011-01-21 | 2012-07-26 | Sun Pharma Advanced Research Company Ltd | Diarylacetylene hydrazide containing tyrosine kinase inhibitors |
| WO2016185490A1 (en) * | 2015-05-18 | 2016-11-24 | Sun Pharma Advanced Research Company Limited | Novel amidoheteroaryl aroyl hydrazide ethynes |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2911040C (en) | 2012-05-02 | 2021-11-16 | Georgetown University | Treating an .alpha.-synucleinopathy with tyrosine kinase inhibitors |
| KR102508288B1 (ko) * | 2016-06-02 | 2023-03-09 | 썬 파마 어드밴스트 리서치 컴패니 리미티드 | 파킨슨병의 치료 |
-
2017
- 2017-06-02 KR KR1020187034626A patent/KR102508288B1/ko active Active
- 2017-06-02 DK DK17743097.2T patent/DK3463351T3/da active
- 2017-06-02 SM SM20220228T patent/SMT202200228T1/it unknown
- 2017-06-02 CN CN201780044265.3A patent/CN109475539B/zh active Active
- 2017-06-02 HU HUE17743097A patent/HUE059387T2/hu unknown
- 2017-06-02 CA CA3024976A patent/CA3024976A1/en active Pending
- 2017-06-02 JP JP2018563062A patent/JP6974357B2/ja active Active
- 2017-06-02 PL PL17743097T patent/PL3463351T3/pl unknown
- 2017-06-02 WO PCT/IN2017/050224 patent/WO2017208267A1/en not_active Ceased
- 2017-06-02 MX MX2018014944A patent/MX385276B/es unknown
- 2017-06-02 AU AU2017273415A patent/AU2017273415B2/en not_active Ceased
- 2017-06-02 PT PT177430972T patent/PT3463351T/pt unknown
- 2017-06-02 RS RS20220497A patent/RS63243B1/sr unknown
- 2017-06-02 US US16/304,914 patent/US10849887B2/en active Active
- 2017-06-02 NZ NZ748592A patent/NZ748592A/en unknown
- 2017-06-02 LT LTEPPCT/IN2017/050224T patent/LT3463351T/lt unknown
- 2017-06-02 ES ES17743097T patent/ES2914782T3/es active Active
- 2017-06-02 SG SG11201810294QA patent/SG11201810294QA/en unknown
- 2017-06-02 EP EP17743097.2A patent/EP3463351B1/en active Active
- 2017-06-02 EP EP22169420.1A patent/EP4085912A1/en active Pending
- 2017-06-02 HR HRP20220683TT patent/HRP20220683T1/hr unknown
- 2017-06-02 UA UAA201812407A patent/UA123018C2/uk unknown
- 2017-06-02 SI SI201731157T patent/SI3463351T1/sl unknown
- 2017-06-02 MY MYPI2018002187A patent/MY193754A/en unknown
-
2018
- 2018-11-21 IL IL263188A patent/IL263188B/en unknown
- 2018-11-22 PH PH12018502457A patent/PH12018502457B1/en unknown
- 2018-11-30 CL CL2018003431A patent/CL2018003431A1/es unknown
-
2020
- 2020-10-01 US US17/061,139 patent/US11583522B2/en active Active
-
2022
- 2022-05-18 US US17/747,472 patent/US11813252B2/en active Active
- 2022-05-27 CY CY20221100369T patent/CY1125285T1/el unknown
-
2023
- 2023-10-11 US US18/378,901 patent/US20240066014A1/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012098416A1 (en) * | 2011-01-21 | 2012-07-26 | Sun Pharma Advanced Research Company Ltd | Diarylacetylene hydrazide containing tyrosine kinase inhibitors |
| WO2016185490A1 (en) * | 2015-05-18 | 2016-11-24 | Sun Pharma Advanced Research Company Limited | Novel amidoheteroaryl aroyl hydrazide ethynes |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11813252B2 (en) | Treatment for Parkinson's disease | |
| US20220233538A1 (en) | Method for treating idiopathic pulmonary fibrosis | |
| JP2005516948A (ja) | 新規な使用 | |
| TW201400118A (zh) | 用於預防及／或治療多囊性腎臟病之藥物 | |
| WO2014179303A1 (en) | Amyloid precursor protein mrna blockers for treating down syndrome and alzheimer's disease | |
| JP2009521470A (ja) | シヌクレイン障害の治療 | |
| HK40082665A (en) | Treatment for parkinson s disease | |
| OA19279A (en) | Treatment for Parkinson's disease. | |
| JP2002506822A (ja) | ＧＡＢＡＡα５逆作動薬とニコチン作動薬との組合わせ | |
| US20030166673A1 (en) | Medicines for the prevention and treatment of neurodegenerative diseases | |
| EA037697B1 (ru) | Лечение болезни паркинсона | |
| BR122024006410A2 (pt) | Uso do composto de fórmula i para o tratamento ou prevenção da doença de parkinson | |
| BR112018074439B1 (pt) | Uso do composto de fórmula i para o tratamento ou prevenção da doença de parkinson | |
| JP2022530890A (ja) | ジアミノピリミジン化合物を使用することによって咳を治療する方法 | |
| ITMI20110208A1 (it) | Eterocicli ad attivita' antiipertensiva | |
| US20190177336A1 (en) | THIENO[2,3-b]PYRIDINE DERIVATIVE AND QUINOLINE DERIVATIVE, AND USE THEREOF | |
| EA046894B1 (ru) | Ингибиторы rho-ассоциированной, содержащей суперспираль протеинкиназы | |
| JP2000505425A (ja) | Ｔｒｈを用いるベータ―アミロイドペプチドに関連する状態の処置方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |